Insulin resistance, or reduced insulin sensitivity, is the key pathophysiologic defect in type 2 diabetes mellitus, metabolic syndrome and cardiovascular disease [1], [2], [3], [4]. This evidence concerns the gene INS and metabolic syndrome.